• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sorrento Therapeutics Inc

+ Add to Watchlist

SRNE:US

8.5000 USD 0.0200 0.24%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Sorrento Therapeutics Inc (SRNE)

Open: 8.6000 Day's Range: 8.2000 - 8.8000 Volume: 585,297
Previous Close: 8.4800 52wk Range: 3.1000 - 16.4000 1-Yr Rtn: +5.99%

Stock Chart for SRNE

No chart data available.
  • SRNE:US 8.5000
  • 1D
  • 1M
  • 1Y
8.4800
Interactive SRNE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SRNE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8300
Est. EPS (USD) (12/2014) -1.2800
Est. PEG Ratio -
Market Cap (M USD) 245.93
Shares Outstanding (M) 28.93
30 Day Average Volume 298,236
Price/Book (mrq) 3.4164
Price/Sale (ttm) 68.1169
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SRNE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SRNE

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease.

Henry JiPresident/CEOZhenwei MiaoChief Technology Officer
George UyChief Commercial OfficerRichard G VincentExec VP/CFO
More Company Profile & Key Executives for SRNE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil